Keyphrases
Endothelial Nitric Oxide Synthase (eNOS)
100%
Aneurysm Formation
100%
Ruptured Abdominal Aortic Aneurysm (rAAA)
100%
Folic Acid
100%
Angiotensin II (Ang II)
85%
Hyperphenylalaninemia
85%
Tetrahydrobiopterin
42%
Methylenetetrahydrofolate Reductase (MTHFR)
42%
Hypertension
28%
Causal Role
28%
Endothelium
28%
Wild Mice
14%
Endothelial Nitric Oxide Synthase Uncoupling
14%
Matrix metalloproteinase-2 (MMP-2)
14%
Overexpression
14%
Gene Therapy
14%
Survivors
14%
Day 14
14%
Macrophage Infiltration
14%
Vascular Inflammation
14%
Elastin
14%
New Therapeutics
14%
Matrix metalloproteinase-9 (MMP-9)
14%
Vascular Remodeling
14%
Oral Administration
14%
Morbidity Rate
14%
Nitric Oxide Deficiency
14%
Salvage Enzymes
14%
Augmented Matrix
14%
Biosynthetic Enzymes
14%
Tetrahydrobiopterin Deficiency
14%
Dihydrofolate Reductase Gene
14%
Total Morbidity
14%
Pharmacology, Toxicology and Pharmaceutical Science
Endothelial Nitric Oxide Synthase
100%
Folic Acid
100%
Abdominal Aortic Aneurysm
100%
Synthetase
85%
Hyperphenylalaninemia
85%
Mouse
71%
Tetrahydrobiopterin
57%
Dihydrofolate Reductase
57%
Nitric Oxide
14%
Gelatinase A
14%
Wild Type Mouse
14%
Angiotensin II
14%
Atherosclerosis
14%
Vasculitis
14%
Elastin
14%
Vascular Remodeling
14%
Gelatinase B
14%
Morbidity
14%
Neuroscience
Endothelial Nitric Oxide Synthase
100%
Folic Acid
100%
Aneurysm
100%
Synthetase
85%
Tetrahydrobiopterin
57%
Dihydrofolate Reductase
57%
Cofactor
14%
Nitric Oxide
14%
MMP2
14%
Macrophage
14%
Angiotensin II
14%
MMP9
14%
Elastin
14%
Biochemistry, Genetics and Molecular Biology
Nitric Oxide Synthase
100%
Folic Acid
100%
Mouse
62%
Tetrahydrobiopterin
50%
Dihydrofolate Reductase
50%
Enzyme
12%
Wild Type Mouse
12%
Wild Type
12%
Angiotensin
12%
Nitric Oxide
12%
Gene Therapy
12%
Macrophage
12%
Elastin
12%
Gelatinase B
12%
MMP9
12%
Gelatinase A
12%
MMP2
12%
Morbidity
12%
Salvage Enzyme
12%